Earnings per ordinary share for the quarter were NT$0.24. Earnings per ADS(Note 2) were US$0.040. The basic weighted average number of outstanding shares in 2Q12 was 12,621,506,549, compared with 12,613,307,158 shares in 1Q12 and 12,513,899,178 shares in 2Q11. The diluted weighted average number of outstanding shares was 13,469,988,568 in 2Q12, compared with 13,420,471,778 shares in 1Q12 and 13,013,072,483 shares in 2Q11. The fully diluted share count on June 30, 2012 was approximately 14,072,176,000. On June 30, 2012, UMC held 300 million treasury shares acquired from the 14th share buy-back program.
Detailed Financials Section
Revenue increased 16.2% QoQ to NT$27.62 billion from NT$23.77 billion in 1Q12, mainly due to increased shipment volume. Other manufacturing costs rose to NT$13.95 billion to correspond with increased wafer shipments. Research and development expenses increased to NT$2,440 million mainly due to an increase for 28nm advanced technology development. The total R&D expense was 8.8% of revenue in 2Q12.
|
COGS & Expenses | |||||
|
(Amount: NT$ million) |
2Q12 |
1Q12 |
QoQ %
|
2Q11 |
YoY %
|
|
Revenue |
27,620 |
23,765 |
16.2 |
28,150 |
(1.9) |
|
COGS |
(20,880) |
(19,215) |
8.7 |
(21,432) |
(2.6) |
|
Depreciation |
(6,932) |
(6,794) |
2.0 |
(6,495) |
6.7 |
|
Other Mfg. Costs |
(13,948) |
(12,421) |
12.3 |
(14,937) |
(6.6) |
|
Gross Profit |
6,740 |
4,550 |
48.1 |
6,718 |
0.3 |
|
Gross Margin (%) |
24.4% |
19.1% |
|
23.9% |
|
|
Total Operating Exp. |
(3,558) |
(3,226) |
10.3 |
(3,398) |
4.7 |
|
G&A |
(626) |
(552) |
13.4 |
(588) |
6.5 |
|
Sales & Marketing |
(492) |
(509) |
(3.3) |
(585) |
(15.9) |
|
R&D |
(2,440) |
(2,165) |
12.7 |
(2,225) |
9.7 |
|
Operating Income |
3,182 |
1,324 |
140.3 |
3,320 |
(4.2) |
